Pyxis Oncology Earnings Estimates, EPS & Revenue | NASDAQ:PYXS

Comments

Pyxis Oncology Inc Earnings Estimates

PYXSNASDAQ

Trade with Public

$1.31

-0.08-5.76%

At close: Mar 27, 5:00 PM EST

$1.29

-0.02-1.53%

After Hours: Mar 27, 7:51 PM EST

Earnings: Q4 2025 Earnings were released on Mon Mar 23rd, before the market open

Overview NewsEarningsOptions Analyst Ratings Insider Trades Short Interest Stock Report

Pyxis Oncology Earnings Estimates, EPS & Revenue | NASDAQ:PYXS

Pyxis Oncology (PYXS) is scheduled to report Q1 earnings on May 14, 2026. Analysts estimate EPS of $-0.36 and quarterly revenue of N/A.

In the most recent quarter (Q4), Pyxis Oncology reported EPS of $-0.29, beating estimates of $-0.34 by 0.15%. Revenue came in at $11.04M, exceeding the estimate of $0.00 by 0.00%.

Over the last 4 quarters, Pyxis Oncology has averaged an EPS surprise of 0.12% and a revenue surprise of 0.00%.

Earnings Date

May 14

EPS Estimate

$-0.360

Quarterly Revenue Estimate

–

Annual Revenue
(as of Dec 31)

$13.86M

Pyxis Oncology Earnings History

Analyze the earnings history of Pyxis Oncology using advanced sorting and filters.

Loading calendar...

Pyxis Oncology (PYXS) Earnings Per Share

The chart below shows Pyxis Oncology's reported EPS compared to analyst estimates over recent quarters.

Pyxis Oncology (PYXS) Revenue

The chart below shows Pyxis Oncology's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Pyxis Oncology (NASDAQ:PYXS) reporting earnings?

Pyxis Oncology (PYXS) is scheduled to report earnings on May 14, 2026. The last reported earnings were for reported on March 23, 2026 for Q4.

What were the latest earnings per share (EPS) for Pyxis Oncology (NASDAQ:PYXS)?

The Actual EPS was $-0.29, which beat the estimate of $-0.34.

What were Pyxis Oncology’s (NASDAQ:PYXS) revenues?

The Actual Revenue was $11.04M, which beat the estimate of $0.00.

People Also Watch

Anixa Biosciences Inc

Gain Therapeutics Inc

NASDAQ:GANX

$1.84

0.55%

Coeptis Therapeutics Holdings Inc

NASDAQ:COEP

$10.68

Inovio Pharmaceuticals Inc

MAIA

PMV Pharmaceuticals Inc

NASDAQ:PMVP

$1.30

-0.50%

Pyxis Oncology Earnings Estimates, EPS & Revenue | NASDAQ:PYXS

Pyxis Oncology (PYXS) is scheduled to report Q1 earnings on May 14, 2026. Analysts estimate EPS of $-0.36 and quarterly revenue of N/A.

In the most recent quarter (Q4), Pyxis Oncology reported EPS of $-0.29, beating estimates of $-0.34 by 0.15%. Revenue came in at $11.04M, exceeding the estimate of $0.00 by 0.00%.

Over the last 4 quarters, Pyxis Oncology has averaged an EPS surprise of 0.12% and a revenue surprise of 0.00%.

Earnings Date

May 14

EPS Estimate

$-0.360

Quarterly Revenue Estimate

–

Annual Revenue
(as of Dec 31)

$13.86M